Aurora Cannabis (ACB) Shares Outstanding (2017 - 2026)

Aurora Cannabis (ACB) posted quarterly Shares Outstanding (Entity) of $413.6 million for Q1 2026, up 8.22% year-on-year from $382.1 million in Q1 2025, and up 1.71% on a QoQ basis from $406.6 million in Q4 2025.

Aurora Cannabis (ACB) Shares Outstanding (2017 - 2026) Analysis & Trends

Aurora Cannabis (ACB) has reported Shares Outstanding (Entity) for 10 consecutive years, with $413.6 million the latest figure, recorded in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 8.22% year-over-year to $413.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $413.6 million (up 8.22% YoY) and the FY2026 annual result came in at $410.4 million, up 4.04% from the prior year.
  • Shares Outstanding (Entity) rose to $413.6 million in Q1 2026 per ACB's latest filing, from $406.6 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Entity) for ACB reached as high as $413.6 million in Q1 2026 and fell as low as $16.9 million in Q2 2022.
  • A 5-year average of $218.0 million and a median of $320.8 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) jumped 1336.73% — and 2025, when it advanced 2.34%.
  • Year by year, Shares Outstanding (Entity) stood at $24.0 million in 2022, then surged by 44.84% to $34.8 million in 2023, then jumped by 1027.76% to $392.8 million in 2024, then increased by 3.5% to $406.6 million in 2025, then advanced by 1.71% to $413.6 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $413.6 million, $406.6 million, and $410.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 8.98 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.16 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 422.10 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 43.50 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 455,871.00
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 100.50 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 497.70 Mn
10 Aurora Cannabis 1.11 Bn 1.03 Bn 21.72 Mn 56.71 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 56.71 Mn
Dec 31, 2025 56.70 Mn
Sep 30, 2025 56.46 Mn
Jun 30, 2025 56.24 Mn
Mar 31, 2025 54.83 Mn
Dec 31, 2024 54.88 Mn
Sep 30, 2024 54.68 Mn
Jun 30, 2024 51.72 Mn
Mar 31, 2024 43.22 Mn
Dec 31, 2023 47.42 Mn
Sep 30, 2023 38.40 Mn
Jun 30, 2023 35.36 Mn
Mar 31, 2023 32.27 Mn
Dec 31, 2022 32.64 Mn
Sep 30, 2022 30.02 Mn
Jun 30, 2022 21.49 Mn
Mar 31, 2022 21.47 Mn
Dec 31, 2021 19.82 Mn
Sep 30, 2021 19.81 Mn
Jun 30, 2021 16.91 Mn